Article

Supplement MIOLs in the ciliary sulcus: Perhaps a good refractive option

Author(s):

The approach seems to provide high levels of spectacle independence and patients' satisfaction, with limited complications associated.

Supplement MIOLs in the ciliary sulcus: Perhaps a good refractive option

More studies with a more robust design are needed to confirm these trends, according to the study.

Spanish investigators who conducted a literature review1 found that the use of supplemental multifocal intraocular lenses (MIOLS) in the ciliary sulcus provide good distance and near visual acuities and high levels of both spectacle independence and patient satisfaction with few complications, according to Carlos Rocha-de-Lossada, MD, from the Ophthalmology Service, Hospital Regional Universitario de Málaga, Málaga, Spain, and colleagues.

The results were based on 15 articles that were selected and reviewed.

The study included 384 eyes of 227 patients. The investigators commented on the limitations of articles, in that they had short follow-up periods and poor or limited designs, e.g., case reports, case series, and clinical trials with several methodologic gaps.

Rocha-de-Lossada reported that the postoperative uncorrected distance and near visual acuities ranged from 20/40 to 20/20 and from 0.4 to 0.02 logarithm of the minimum angle of resolution, respectively.

The complications that were mentioned most often were pigment dispersion in 12 eyes and deposits in 13 eyes. The most common visual disruptions were dysphotopsia, glare, and halos.

Despite this, most patients were highly satisfied with the surgery.

The researchers pointed out that 13 of the 15 articles reviewed achieved a risk-of-bias score between 6 and 8, which represents a high level of evidence despite the limitations of the study designs.

The study concluded, “Supplemental MIOLs seem to offer good distance and near visual results, leading to high levels of spectacle independence and patients' satisfaction, with limited complications associated. However, more studies with a more robust design are needed to confirm these trends.”

Reference
  1. Rocha-de-Lossada C, Zamorano-Mattin F, Piñero DP, et al. Systematic review of the use of supplemental multifocal intraocular lenses in the ciliary sulcus for presbyopia correction. J Refract Surg. 2021;37:830–835; published online: December 01, 2021; https://doi.org/10.3928/1081597X-20210920-01

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
© 2025 MJH Life Sciences

All rights reserved.